MB Venture Partners
Gary Stevenson, Co-Founder and Managing Partner
Gary Stevenson co-founded MB Venture Partners in 2001 after six years in healthcare investment banking and equity research. At MBVP, he has raised $120 million in committed capital to four funds and invested in more than 50 start-ups, most of which are focused on product solutions for musculoskeletal disease. He also spent seven years in a variety of general management roles with Abbott Laboratories. Gary holds an undergraduate degree in accounting from the University of Missouri. He also received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University. He is a certified public accountant and a chartered financial analyst. Gary is a board member or observer for several MBVP portfolio companies. Medtronic, Smith + Nephew, Zimmer Biomet, and Wright Medical have each acquired MBVP-funded start-ups. This will be his 18th year to host the MNVC.
CrossRoads Extremity Systems
Vernon Hartdegen, President & CEO
Chad Hollis, Co-Founder and VP of R&D
Headquartered in Memphis, TN, CrossRoads was founded in 2014 by Glen Coleman, Vernon Hartdegen and Chad Hollis. The Company’s mission is to develop and commercialize breakthrough technologies in the orthopedic extremity sector that improve the operating room experience and patient outcomes through simplicity and accuracy for the surgeon, and sustainability and cost reduction for healthcare institutions. CrossRoads’ Staple Compression Plate™ technology is the only technology on the market today to simultaneously offer enhanced stability with continuous compression, optimizing conditions for bone healing in fusion procedures. The Company leverages this technology in a broad range of procedure-specific, sterile-packed implants and instrumentation systems cleared for both lower and upper extremity indications. The Company’s EcoSMART® Instrument Service provides customers with gamma sterilized, reusable instruments for every surgical case and post-surgery recovery and processing of those instruments. EcoSMART® reduces the inefficiencies of traditional reusable instrument trays.
IlluminOss Medical, Inc.
Bob Rabiner, Chief Technical Officer
Mike Mogul, Chairman
IlluminOss Medical, Inc. is a privately held, commercial-stage medical device company offering a unique, minimally invasive technology for the repair and stabilization of fractures in poor quality weakened bone; particularly applicable for osteoporotic and pathologically compromised bone. The IlluminOss system utilizes a light-curable liquid monomer which is infused and contained within a conformal balloon sized to the patient’s anatomy and then illuminated with visible blue light converting the liquid to a strong hardened polymer, creating a patient-conforming intramedullary implant. The cured implant conforms to the shape of the patient’s intramedullary canal, providing rapid strength and stability to the compromised bone. Designed as a stand-alone implant, however should supplemental fixation devices be needed, they can be placed anywhere along the implant. The speed, simplicity and minimally invasive procedure has permitted the majority of patients treated with IlluminOss to return to their daily living activities far sooner and with less use of post-operative pain medications. Used in over 4000 patients in Europe, IlluminOss has been recently launched in the United States for general trauma use. The IlluminOss system is both FDA-cleared and CE marked for a wide variety of anatomical sites, with further indications pending. IlluminOss is headquartered in East Providence, RI.
Bryan Lord, Co-Founder, CEO
Dave Carey, Chief Commercial Officer
Pristine Surgical is dedicated to improving the surgical episode for patient, surgeon and center in endoscopic procedures via our single-use digital visualization platform. We provide consistently clear images with a brand-new endoscope, every time.
Richard Treadwell, President & CEO
Louie Fielding, COO and co-founder
Richard is an accomplished senior executive with more than 25 years of operating experience and a deep understanding of general management in healthcare. He has held functional leadership roles in marketing, business development, engineering and product development. As a founder of two Bay Area-based startups, he has demonstrated entrepreneurial acumen with fundraising, P&L and operating leadership. Richard has achieved consistent excellent results across a broad range of medical device therapeutic areas, including interventional cardiology at Biosensors International, cardiac surgery at Embol-X, pulse-oximetry at Nellcor, orthodontic support at Align Technology/General Orthodontic and otolaryngology at Aardvark Medical. Richard holds an MBA from The Wharton School at the University of Pennsylvania, as well as an MA in International Relations from the Johns Hopkins School of Advanced International Studies (SAIS) and a BS from Stanford University in Engineering (Product Design).